2011/08/24 by Justin H. Turner, Douglas D. Reh · 604 citations
Medicine · #Adenocarcinoma #Basal cell #Bone Tumor Diagnosis and Treatments #Cancer #Cancer registry #Ear and Head Tumors #Environmental health #Epidemiology #Head and Neck Surgical Oncology #Incidence (geometry) #Internal medicine #Medicine #Nasal cavity #Oncology #Population #Radiation therapy #Relative survival #Surgery #Surveillance, Epidemiology, and End Results
paper · doi:10.1002/hed.21830
published in Head & Neck 34(6), 877-885 (Wiley)
openalex publication_date 2011/08/24 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04
BACKGROUND: The present study uses population-based data from the Surveillance, Epidemiology, and End Results (SEER) database to evaluate the behavior of sinonasal tumors. METHODS: Data for all sinonasal malignancies reported between 1973 and 2006 (n = 6739) were extracted from the database. Time-dependent trends in incidence and survival were analyzed by linear regression. RESULTS: The overall incidence of sinonasal cancer was 0.556 cases per 100,000 population per year with a male:female ratio of 1.8:1. The most common histologies were squamous cell carcinoma (51.6%) and adenocarcinoma (12.6%), whereas the most common primary sites were the nasal cavity (43.9%) and maxillary sinus (35.9%). The incidence of sinonasal cancer remained relatively stable during the study period. No significant changes in overall relative survival were noted. The best relative survival was noted in patients treated with surgery or a combination of surgery and radiotherapy. CONCLUSIONS: The prognosis of patients with sinonasal cancer is generally poor, and has not changed substantially over the last 3 decades.